Skip to main content
White Paper
Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United States
- Sharon Phares,
- Mark Trusheim,
- Sarah K Emond, and
- Steven D Pearson
e240118
Published Online:14 November 2024
Improving access to gene therapies: a holistic view of current challenges and future policy solutions in the United States
- Tyler D Wagner,
- Lisabeth Buelt,
- Kimberly Westrich, and
- Jonathan D Campbell
e240098
Published Online:19 November 2024
Research Article
Healthcare costs and resource utilization of patients with chronic post-traumatic stress disorder: a retrospective US claims analysis of commercially insured patients
- Filip Stanicic,
- Vladimir Zah,
- Dimitrije Grbic,
- Debra de Angelo, and
- Wendy Bibeau
e240058
Published Online:13 November 2024
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study
- Yestle Kim,
- Joseph Medicis,
- Matthew Davis,
- Dominic Nunag, and
- Robert Gish
e240096
Published Online:22 November 2024
Real-world clinical outcomes and rationale for initiating abatacept as a first-line biologic for patients with anticitrullinated protein antibody- and rheumatoid factor-positive rheumatoid arthritis
- Alexandrina Balanean,
- Cherrishe Brown-Bickerstaff,
- Andrew Klink,
- Vardhaman Patel,
- Hanke Zheng,
- Laetitia N'Dri,
- Keith Wittstock,
- Bruce Feinberg,
- Mark Chaballa,
- Vadim Khaychuk,
- Jill Kaufman,
- Prathamesh Pathak, and
- Gordon Lam
e230144
Published Online:18 November 2024
A novel injection device to administer repository corticotropin injection for inflammatory disease treatment: findings from a market research study
- Sheila Elliott,
- Priya Miranda, and
- Kyle Hayes
e240131
Published Online:11 November 2024
Review
Clinical assessment of the potential use of a novel single-dose prefilled injection device for the administration of Acthar Gel in children: a narrative review
- Johanna Purcell and
- Sheila Elliott
e240132
Published Online:25 October 2024
Perspective
Advancing the role of real-world evidence in comparative effectiveness research
- Monica Daigl,
- Seye Abogunrin,
- Felipe Castro,
- Sarah F McGough,
- Rachele Hendricks Sturrup,
- Cornelis Boersma, and
- Keith R Abrams
e240101
Published Online:11 October 2024
Corrigendum
Corrigendum
e240219
Published Online:21 November 2024
- Correction(s) for this article
Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis utilizing patient-level and aggregate data
- Volume 13Issue 10Journal of Comparative Effectiveness Research
- 17 September 2024